Hookipa Pharma Valuation
| HOOK Stock | USD 2.48 0.16 6.90% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Hookipa Pharma retains a regular Real Value of $2.38 per share. The prevalent price of the firm is $2.48. Our model calculates the value of Hookipa Pharma from evaluating the firm fundamentals such as Return On Equity of -0.49, return on asset of -0.2, and Current Valuation of (27.03 M) as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Hookipa Pharma's valuation include:
Price Book 0.4164 | Enterprise Value -27 M | Enterprise Value Ebitda 0.4569 | Price Sales 0.5731 | Enterprise Value Revenue 1.9077 |
Overvalued
Today
Please note that Hookipa Pharma's price fluctuation is very risky at this time. Calculation of the real value of Hookipa Pharma is based on 3 months time horizon. Increasing Hookipa Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Hookipa Pharma's intrinsic value may or may not be the same as its current market price of 2.48, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.48 | Real 2.38 | Target 4.82 | Hype 2.48 | Naive 2.29 |
The intrinsic value of Hookipa Pharma's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Hookipa Pharma's stock price.
Estimating the potential upside or downside of Hookipa Pharma helps investors to forecast how Hookipa stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Hookipa Pharma more accurately as focusing exclusively on Hookipa Pharma's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Hookipa Pharma's intrinsic value based on its ongoing forecasts of Hookipa Pharma's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Hookipa Pharma's closest peers.
Hookipa Pharma Cash |
|
Hookipa Valuation Trend
Knowing Hookipa Pharma's actual value is paramount for traders when making sound investment determinations. Using both Hookipa Pharma's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Hookipa Pharma Total Value Analysis
Hookipa Pharma is currently estimated to have valuation of (27.03 M) with market capitalization of 29.9 M, debt of 6.56 M, and cash on hands of 117.92 M. The negative valuation of Hookipa Pharma may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Hookipa Pharma fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(27.03 M) | 29.9 M | 6.56 M | 117.92 M |
Hookipa Pharma Investor Information
About 21.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.42. Some equities with similar Price to Book (P/B) outperform the market in the long run. Hookipa Pharma recorded a loss per share of 3.67. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 10th of July 2024. Based on the key measurements obtained from Hookipa Pharma's financial statements, Hookipa Pharma is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December.Hookipa Pharma Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Hookipa Pharma has an asset utilization ratio of 12.48 percent. This suggests that the Company is making $0.12 for each dollar of assets. An increasing asset utilization means that Hookipa Pharma is more efficient with each dollar of assets it utilizes for everyday operations.Hookipa Pharma Ownership Allocation
The market capitalization of Hookipa Pharma is $29.9 Million. Hookipa Pharma secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Hookipa Pharma Profitability Analysis
The company reported the previous year's revenue of 20.13 M. Net Loss for the year was (81.58 M) with loss before overhead, payroll, taxes, and interest of (52.97 M).About Hookipa Pharma Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Hookipa Pharma. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Hookipa Pharma based exclusively on its fundamental and basic technical indicators. By analyzing Hookipa Pharma's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Hookipa Pharma's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Hookipa Pharma. We calculate exposure to Hookipa Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Hookipa Pharma's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 16.6 M | 12.4 M | |
| Pretax Profit Margin | (4.03) | (4.24) | |
| Operating Profit Margin | (4.85) | (5.10) | |
| Net Loss | (4.05) | (4.26) | |
| Gross Profit Margin | 0.82 | 0.86 |
Hookipa Pharma Growth Indicators
Investing in growth stocks can be very risky. If the company such as Hookipa Pharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 9.5 M |
Hookipa Pharma Current Valuation Indicators
Hookipa Pharma's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Hookipa Pharma's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Hookipa Pharma, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Hookipa Pharma's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Hookipa Pharma's worth.When determining whether Hookipa Pharma is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Hookipa Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Hookipa Pharma Stock. Highlighted below are key reports to facilitate an investment decision about Hookipa Pharma Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hookipa Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Hookipa Stock please use our How to buy in Hookipa Stock guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hookipa Pharma. If investors know Hookipa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hookipa Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.67) | Revenue Per Share 4.403 | Quarterly Revenue Growth (0.52) | Return On Assets (0.20) | Return On Equity (0.49) |
The market value of Hookipa Pharma is measured differently than its book value, which is the value of Hookipa that is recorded on the company's balance sheet. Investors also form their own opinion of Hookipa Pharma's value that differs from its market value or its book value, called intrinsic value, which is Hookipa Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hookipa Pharma's market value can be influenced by many factors that don't directly affect Hookipa Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hookipa Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hookipa Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hookipa Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.